Peta ラジオ波焼灼(RFA)システム、神経

A チタン または 合金 胸骨プレート・システム 厳しい 胸骨正中切開後の固定、強化 胸骨の安定性 心臓手術後の感染や剥離のリスクを軽減する。

Peta RFA, offered by Invamed—a global medical device manufacturer—focuses on ラジオ波焼灼療法 (RFA) technology to target specific nerves transmitting pain signals. Primarily applied for facet joint pain, sacroiliac joint disorders, or chronic back/neck pain, Peta RFA harnesses controlled heat to disrupt nerve conduction, minimizing or eliminating persistent pain.

Precision Nerve Focus

Identifies and ablates the sensory nerves that transmit pain from the spine (facet or SI joints), offering lasting relief for chronic pain sufferers.

Utilizes RF energy to generate localized heat, interrupting nerve function and reducing pain perception without excessive damage to adjacent tissues.

Ideal for facet joint arthropathy in cervical, thoracic, lumbar regions, sacroiliac (SI) joint pain syndromes, or chronic axial back and neck pain unresponsive to conservative therapies.

Radiofrequency ablation precisely confines thermal energy to targeted nerves, sparing healthy structures and facilitating quicker patient recovery compared to open surgical interventions.

Active infection at the operative site, severe coagulopathy, or certain comorbid conditions that preclude percutaneous procedures; verify patient eligibility before proceeding.

Identifies and ablates the sensory nerves that transmit pain from the spine (facet or SI joints), offering lasting relief for chronic pain sufferers.

Utilizes RF energy to generate localized heat, interrupting nerve function and reducing pain perception without excessive damage to adjacent tissues.

Ideal for facet joint arthropathy in cervical, thoracic, lumbar regions, sacroiliac (SI) joint pain syndromes, or chronic axial back and neck pain unresponsive to conservative therapies.

Radiofrequency ablation precisely confines thermal energy to targeted nerves, sparing healthy structures and facilitating quicker patient recovery compared to open surgical interventions.

Active infection at the operative site, severe coagulopathy, or certain comorbid conditions that preclude percutaneous procedures; verify patient eligibility before proceeding.